Acute Intermittent Porphyria (AIP) is a rare genetic disease characterized by attacks of severe abdominal pain, vomiting, and neurological abnormalities. The condition results from a deficiency in the enzyme porphobilinogen deaminase (PBGD). Symptoms include severe abdominal pain, nausea or vomiting, constipation, and other neurological symptoms su
Actemra Drug Market Poised to Grow at Highest Pace Owing to Rising Geriatric Population
The actemra drug market is experiencing high demand owing to the increasing prevalence of rheumatoid arthritis in the geriatric population. Actemra, also known as tocilizumab, is a prescription medication used to treat rheumatoid arthritis, giant cell arteritis, and cytokine release syndrome. The drug belongs to a class of medications called interl
Acoustic Neuroma Market will grow at highest pace owing to increasing prevalence of cancer
The acoustic neuroma market comprises products such as surgery devices, medication and others required for the diagnosis and treatment of acoustic neuromas. Acoustic neuromas, also called vestibular schwannomas, are non-cancerous tumors that develop on the nerve connecting the ear to the brain. Acoustic neuroma growths can cause hearing loss, ringi
The Rising Acid Sphingomyelinase Deficiency (ASMD) Market Set to Grow at Highest Pace Owing to Increasing Research and Development Activities
ASMD is a rare, inherited genetic disorder in which kids are born deficient in an enzyme called acid sphingomyelinase (ASM). This enzyme plays a key role in breaking down a fatty substance called sphingomyelin. A deficiency in this enzyme results in the abnormal accumulation of sphingomyelin in various tissues, especially in cells of the liver, spl